ORIGINAL RESEARCH
Accepted on 10 Oct 2025
Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer
doi 10.3389/fimmu.2025.1656593
- 155 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Therapeutics in Rare Cancers: Targeting Tumor Microenvironment and Biomarker-Driven Approaches
Precision Therapeutics in Rare Cancers: Targeting Tumor Microenvironment and Biomarker-Driven Approaches
3,221
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 26 Sep 2025
Targeting PD-L1 for PCNS-DLBCL: from molecular effects to clinical translation
doi 10.3389/fimmu.2025.1647045
- 1,024 views
REVIEW
Published on 21 Jul 2025
Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications
doi 10.3389/fimmu.2025.1612352
- 2,041 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Jul 2025
Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling
doi 10.3389/fimmu.2025.1605227
- 1,210 views
ORIGINAL RESEARCH
Published on 20 Jun 2025
Immune profiling of pediatric germ cell tumors identifies key cell populations and novel therapeutic targets
doi 10.3389/fimmu.2025.1579948
- 1,656 views
CASE REPORT
Published on 24 Jan 2025
Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
doi 10.3389/fonc.2025.1465645
- 1,072 views
- 1 citation
ORIGINAL RESEARCH
Published on 29 Jul 2024
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma
doi 10.3389/fimmu.2024.1390873
- 3,949 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
T Cell Biology
NK and Innate Lymphoid Cell Biology
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: